The evidence standard
Validity,
not volume
We do not compete on how many biomarkers we run. We compete on whether they mean anything.
Every marker named on this site is validated, guideline-supported, and changes what we do. If a test cannot alter a clinical decision, we will tell you that before you pay for it — and we will not put it in a headline.
The number
68
Distinct laboratory assays
~120
Individually reported values
35
Grade A markers — the published panel
A panel built around 35 established, guideline-supported markers, extended by emerging and investigational measures under an explicit evidence-grading framework. Each assay is returned with its grade.
The grading framework
Grade A · Established
35 assays
Validated assay, supported by clinical guidelines, with a defined action attached to an abnormal result. These are the only markers named anywhere on this website.
Grade B · Emerging
22 assays
Validated assays with an evolving evidence base. They inform discussion in the interpretation consult. They do not independently drive treatment, and they are not sold to you in a headline.
Grade C · Investigational
11 assays
Epigenetic clocks, telomere length, oxidative stress markers, mineral and amino acid panels, microbiome. Opt-in, separately consented, separately itemised, reported as trend without clinical interpretation, as participation in our research registry.
Why a bigger number is not a better panel
A larger count is easier to produce than a smaller defensible one. Four mechanisms account for most of the difference.
Component splitting
One complete blood count becomes fifteen “biomarkers.” One lipid panel becomes eight. One metabolic panel becomes fourteen. The blood draw did not change; the marketing did.
Counting arithmetic as measurement
Non-HDL cholesterol, the LDL/HDL ratio and eGFR are calculations performed on values already counted once. Counting them again doubles the number without adding a test.
Padding with unvalidated assays
Multi-mineral shotgun panels, oxidative-stress markers with unstable pre-analytics, and proprietary composite scores with no published validation raise a count at essentially zero evidentiary cost.
Counting what you did not buy
Opt-in add-ons folded into the headline figure, whether or not the patient in front of you ordered them.
What we claim, and what we do not
Where the evidence is settled, we say so and we act on it. Where it is not, we say that too — and we measure you before and after, on our own instruments, so that you and we find out.
| Category | The claim made | The claim not made |
|---|---|---|
| Biomarker panel | Every marker named is validated, guideline-supported, and attached to a clinical action. | — |
| Whole-body MRI | A complete structural survey, read by a named physician inside the full physiological dataset, with a defined follow-up pathway. | That screening reduces mortality. |
| Regenerative programme | A defined protocol, disclosed sourcing, monitored delivery, and re-measurement against your own baseline on the same instruments. | That the therapy is proven. |
This position is available to us because we own the assessment engine upstream of the therapy. A clinic that only sells therapy cannot make it. A clinic that only sells diagnostics has nothing to measure.
Questions we are asked
Another clinic advertises far more biomarkers. Why do you run fewer?
Because most of that difference is counting, not testing. A single complete blood count can be presented as one test or as fifteen biomarkers; a lipid panel as one test or as eight. Beyond that, panels are commonly extended with assays that have no established interpretation at the individual level — they produce a number, but no decision follows from it. Our panel is built the other way around. We start from the question of what would change our management of you, and we test that. Where we do measure something whose meaning is still being established, we say so on the report, and we do not act on it alone. The measure that matters is not how many results you receive. It is how many of them your physician can do something with.
What is the actual number?
68 distinct laboratory assays, returning approximately 120 individually reported values. 35 of those assays are Grade A. Where a count appears anywhere on this site, it is that number.
Can I still have the epigenetic and investigational tests?
Yes, at consult, under separate written consent and separate itemised cost, as participation in the clinic's research registry. They are reported to you as trend. No biological age number is issued as a clinical result, because none of the available clocks supports one at the individual level.
How do I know which grade a result is?
It is printed beside the number on your report, on every result, every time.
Request a consult
Discuss Evidence standard enquiry with a physician
Choose the clinic and the dates that suit you. Every course begins with an assessment, and we will tell you plainly if this is not the right intervention for you.
Interventions restricted under Canadian regulation are delivered at our Costa Rica clinic, under the same physicians and the same protocol.